AbundRX Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: straightforward two-tier compounded GLP-1 pricing with free shipping
Price is where AbundRX scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
AbundRX (Abundant Wellness) connects patients with licensed clinicians for compounded GLP-1 treatment after a short online assessment. It advertises semaglutide-based care 'Starting at $99' and tirzepatide-based care 'Starting at $149', with fast free shipping. Neither figure carries a billing period, though, and the intake applies a $120 first-month discount, so the ongoing rate is unpublished. Compounded medications are not FDA-approved (disclosed). It claims LegitScript certification without a verifiable seal and does not name its pharmacy.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to AbundRX
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
AbundRX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo (“starting at” price)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored AbundRX
Each dimension is scored algorithmically from AbundRX’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.7/10At $99/mo (“starting at” price), AbundRX runs about 45% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
7.7/10AbundRX offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
6.9/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.7/10AbundRX's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.5/10AbundRX provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this AbundRX review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $99–$149/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with AbundRX
We walked AbundRX’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a brief online health assessment/intake about your history, needs and goals.
- 2A licensed provider reviews your case and may recommend treatment and a care plan when appropriate.
- 3If prescribed, medication is prepared by a licensed pharmacy and shipped to your home where permitted.
- 4Ongoing follow-up and support may be available throughout care.
- Pricing shown upfront: semaglutide-based care starting at $179, tirzepatide-based care starting at $279; FAQ repeats these starting prices.
- Site markets LegitScript certification and 'transparent/straightforward pricing.'
- Final pricing may vary depending on the treatment path selected through clinical review.
- Expedited/free delivery may be available at no additional cost when prescribed.
- A Refund Policy page is linked but specific terms were not shown.
AbundRX customer support
- Phone
- +1 833-493-7130
GLP-1 medications AbundRX offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
'Starting at $99' for semaglutide-based care. The site does not publish the ongoing monthly rate.
'Starting at $149' for tirzepatide-based care. The site does not publish the ongoing monthly rate.
Ready to get started?
Plans and promotions change often, so check AbundRX's current pricing and active discounts before you decide.
What we like
- Two clear compounded GLP-1 pathways with transparent pricing: semaglutide $179/mo and tirzepatide $279/mo
- Fast, free shipping and a simple few-minute online health assessment
- Provider-guided care connecting patients with licensed US clinicians
- Publishes Terms, Privacy, and Refund policies
Watch-outs
- Claims LegitScript certification in text but displays no verifiable seal or listing
- Compounded medications are not FDA-approved (the site discloses this) and are not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Compounding pharmacy not named; no HIPAA notice found; state availability not published
- Heavily hedged marketing language ('may include', 'helping connect patients') that reads like a lead-generation platform
Is AbundRX worth it?
The short version of what AbundRX offers is straightforward two-tier compounded GLP-1 pricing with free shipping. It runs $99/month (“starting at” price); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
How much AbundRX costs
Compounded semaglutide runs $99/month (“starting at” price) and compounded tirzepatide runs $149/month (“starting at” price).
Because AbundRX's headline figure is a “starting at” price, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare AbundRX with the month-to-month prices of the alternatives below instead.
Eden (about $99/month) is one of the closest alternatives to weigh AbundRX against.
Medications: what AbundRX prescribes
AbundRX prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Who AbundRX is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
AbundRX is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Price is where AbundRX scores best in our breakdown.
Ready to start with AbundRX?
From $99/mo (“starting at” price). See current pricing and start your free consultation.
AbundRX might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare AbundRX vs…
AbundRX scores7.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
AbundRX vs Amazon One Medical
Amazon One Medical scores 8.5/10
AbundRX vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this AbundRX review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See AbundRX's current pricing
Plans from $99/mo (“starting at” price). Start your free consultation to check eligibility and today's price.